Literature DB >> 16162679

Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice.

K Yoshihara1, T Yajima, C Kubo, Y Yoshikai.   

Abstract

BACKGROUND AND AIMS: Interleukin (IL)-15 is a member of the IL-2 family, stimulating dendritic cells, natural killer (NK) cells, NK T cells and memory CD8+ T cells. IL-15 levels were elevated in the intestinal mucosa of inflammatory bowel diseases. Here we investigated the involvement of IL-15 in the pathogenesis of acute and chronic dextran sulphate sodium (DSS) induced colitis.
METHODS: IL-15 knockout (KO) mice and control C57BL/6 mice were used to induce colitis with DSS in their drinking water. Survival rate, clinical activity of diseases, extent of tissue damage, leucocyte population, and cytokine production of lamina propria (LP) cells of the large intestines were assessed.
RESULTS: IL-15 KO mice exhibited resistance to DSS induced acute colitis, as reflected by lower lethality, weight loss, clinical scores, and histological scores compared with those in control mice (p<0.05). The proportions of CD44(high) CD8+ T cells and NK cells in LP cells and levels of interferon (IFN)-gamma, tumour necrosis factor (TNF)-alpha, and IL-12p40 in culture supernatants of LP cells were reduced in IL-15 KO mice (p<0.05). In vivo depletion of CD8+ T cells and NK cells decreased levels of IFN-gamma, TNF-alpha, and IL-12p40 in culture supernatants of LP cells in C57BL/6 mice (p<0.01). In chronic colitis, weight loss and clinical scores were improved and levels of IFN-gamma, TNF-alpha, and IL-12p40 in culture supernatants of LP cells were also reduced in IL-15 KO mice (p<0.05).
CONCLUSIONS: IL-15 plays an important role in the pathogenesis of both acute and chronic colitis induced by DSS in mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16162679      PMCID: PMC1856088          DOI: 10.1136/gut.2005.076000

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  52 in total

1.  IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation.

Authors:  R J Armitage; B M Macduff; J Eisenman; R Paxton; K H Grabstein
Journal:  J Immunol       Date:  1995-01-15       Impact factor: 5.422

2.  Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.

Authors:  D Rachmilewitz; J S Stamler; D Bachwich; F Karmeli; Z Ackerman; D K Podolsky
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

3.  The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.

Authors:  R N Bamford; A J Grant; J D Burton; C Peters; G Kurys; C K Goldman; J Brennan; E Roessler; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

4.  Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor.

Authors:  K H Grabstein; J Eisenman; K Shanebeck; C Rauch; S Srinivasan; V Fung; C Beers; J Richardson; M A Schoenborn; M Ahdieh
Journal:  Science       Date:  1994-05-13       Impact factor: 47.728

5.  Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.

Authors:  D Rachmilewitz; F Karmeli; E Okon; M Bursztyn
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

6.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.

Authors:  F Powrie; M W Leach; S Mauze; S Menon; L B Caddle; R L Coffman
Journal:  Immunity       Date:  1994-10       Impact factor: 31.745

7.  Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.

Authors:  L A Dieleman; B U Ridwan; G S Tennyson; K W Beagley; R P Bucy; C O Elson
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

8.  Identical T cell clones are located within the mouse gut epithelium and lamina propia and circulate in the thoracic duct lymph.

Authors:  T Arstila; T P Arstila; S Calbo; F Selz; M Malassis-Seris; P Vassalli; P Kourilsky; D Guy-Grand
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

9.  Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15.

Authors:  J G Giri; M Ahdieh; J Eisenman; K Shanebeck; K Grabstein; S Kumaki; A Namen; L S Park; D Cosman; D Anderson
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

10.  Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.

Authors:  W E Carson; J G Giri; M J Lindemann; M L Linett; M Ahdieh; R Paxton; D Anderson; J Eisenmann; K Grabstein; M A Caligiuri
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  34 in total

1.  IL-15 suppresses colitis-associated colon carcinogenesis by inducing antitumor immunity.

Authors:  Rajia Bahri; Ioannis S Pateras; Orietta D'Orlando; Diego A Goyeneche-Patino; Michelle Campbell; Julia K Polansky; Hilary Sandig; Marilena Papaioannou; Kostas Evangelou; Periklis G Foukas; Vassilis G Gorgoulis; Silvia Bulfone-Paus
Journal:  Oncoimmunology       Date:  2015-01-22       Impact factor: 8.110

Review 2.  Interleukin 15: its role in intestinal inflammation.

Authors:  D A van Heel
Journal:  Gut       Date:  2006-04       Impact factor: 23.059

3.  Targeting F box protein Fbxo3 to control cytokine-driven inflammation.

Authors:  Rama K Mallampalli; Tiffany A Coon; Jennifer R Glasser; Claire Wang; Sarah R Dunn; Nathaniel M Weathington; Jing Zhao; Chunbin Zou; Yutong Zhao; Bill B Chen
Journal:  J Immunol       Date:  2013-10-11       Impact factor: 5.422

4.  TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.

Authors:  Hidetoshi Takedatsu; Kathrin S Michelsen; Bo Wei; Carol J Landers; Lisa S Thomas; Deepti Dhall; Jonathan Braun; Stephan R Targan
Journal:  Gastroenterology       Date:  2008-05-07       Impact factor: 22.682

5.  Intestinal mononuclear cells primed by systemic interleukin-12 display long-term ability to aggravate colitis in mice.

Authors:  Luciano P Pedrotti; Angela A Sena; María Cecilia Rodriguez Galán; Hugo Cejas; Silvia G Correa
Journal:  Immunology       Date:  2016-11-27       Impact factor: 7.397

6.  Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis.

Authors:  Laila D McVay; Sue A Keilbaugh; Tracie M H Wong; Sonja Kierstein; Marcus E Shin; Michael Lehrke; Martina I Lefterova; D Edward Shifflett; Sean L Barnes; Fabio Cominelli; Steven M Cohn; Gail Hecht; Mitchell A Lazar; Angela Haczku; Gary D Wu
Journal:  J Clin Invest       Date:  2006-10-05       Impact factor: 14.808

7.  Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization.

Authors:  Timothy L Denning; Brian A Norris; Oscar Medina-Contreras; Santhakumar Manicassamy; Duke Geem; Rajat Madan; Christopher L Karp; Bali Pulendran
Journal:  J Immunol       Date:  2011-06-10       Impact factor: 5.422

8.  Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab.

Authors:  Clémentine Perrier; Ingrid Arijs; Dominiek Staelens; Christine Breynaert; Isabelle Cleynen; Kris Covens; Marc Ferrante; Gert Van Assche; Séverine Vermeire; Gert de Hertogh; Frans Schuit; Paul Rutgeerts; Jan L Ceuppens
Journal:  Immunology       Date:  2013-01       Impact factor: 7.397

9.  Interleukin-33 exacerbates acute colitis via interleukin-4 in mice.

Authors:  Peter N Pushparaj; Dong Li; Mousa Komai-Koma; Rodrigo Guabiraba; James Alexander; Charles McSharry; Damo Xu
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

10.  Deletion of cationic amino acid transporter 2 exacerbates dextran sulfate sodium colitis and leads to an IL-17-predominant T cell response.

Authors:  Kshipra Singh; Lori A Coburn; Daniel P Barry; Mohammad Asim; Brooks P Scull; Margaret M Allaman; Nuruddeen D Lewis; M Kay Washington; Michael J Rosen; Christopher S Williams; Rupesh Chaturvedi; Keith T Wilson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-05-23       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.